News @ Praesidia

Praesidia is built on the vision of being a patient focused and clinician driven drug development company championing unmet clinical needs.

Praesidia conceptualized

Series A funding received

Technology proof achieved for 2 indications in 2 target tissues

Raise Series B
Funding

Ph I clinical trial with at least 1 asset and IND
development of current and new drugs